Mario Gabelli Poseida Therapeutics, Inc. Transaction History
Gamco Investors, Inc. Et Al
- $8.8 Billion
- Q4 2024
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 20,000 shares of PSTX stock, worth $190,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$190,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PSTX
# of Institutions
119Shares Held
40.7MCall Options Held
135KPut Options Held
439K-
Pentwater Capital Management LP Naples, FL8.63MShares$81.9 Million0.95% of portfolio
-
Nomura Holdings Inc Tokyo, M05.12MShares$48.6 Million0.07% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$46.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.83MShares$36.4 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.02MShares$19.2 Million1.2% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $815M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...